Maini RN - Search Results

1

TNF alpha is an effective therapeutic target for rheumatoid arthritis.

Feldmann M, Brennan FM, Elliott MJ, Williams RO, Maini RN. Feldmann M, et al. Among authors: maini rn. Ann N Y Acad Sci. 1995 Sep 7;766:272-8. doi: 10.1111/j.1749-6632.1995.tb26675.x. Ann N Y Acad Sci. 1995. PMID: 7486670 Review.

2

Discovery of TNF-alpha as a therapeutic target in rheumatoid arthritis: preclinical and clinical studies.

Feldmann M, Maini RN. Feldmann M, et al. Among authors: maini rn. Joint Bone Spine. 2002 Jan;69(1):12-8. doi: 10.1016/s1297-319x(01)00335-9. Joint Bone Spine. 2002. PMID: 11858351 Review.

3

How does infliximab work in rheumatoid arthritis?

Maini RN, Feldmann M. Maini RN, et al. Arthritis Res. 2002;4 Suppl 2(Suppl 2):S22-8. doi: 10.1186/ar549. Epub 2002 Mar 27. Arthritis Res. 2002. PMID: 12110154 Free PMC article. Review.

4

Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases.

Feldmann M, Maini RN. Feldmann M, et al. Among authors: maini rn. Nat Med. 2003 Oct;9(10):1245-50. doi: 10.1038/nm939. Nat Med. 2003. PMID: 14520364 No abstract available.

5

Anti-TNFalpha therapy of rheumatoid arthritis: what can we learn about chronic disease?

Feldmann M, Brennan FM, Paleolog E, Cope A, Taylor P, Williams R, Woody J, Maini RN. Feldmann M, et al. Among authors: maini rn. Novartis Found Symp. 2004;256:53-69; discussion 69-73, 106-11, 266-9. Novartis Found Symp. 2004. PMID: 15027483 Review.

6

The transfer of a laboratory based hypothesis to a clinically useful therapy: the development of anti-TNF therapy of rheumatoid arthritis.

Feldmann M, Brennan FM, Williams RO, Woody JN, Maini RN. Feldmann M, et al. Among authors: maini rn. Best Pract Res Clin Rheumatol. 2004 Feb;18(1):59-80. doi: 10.1016/j.berh.2003.09.010. Best Pract Res Clin Rheumatol. 2004. PMID: 15123038 Review.

7

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha.

Elliot MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katasikis P, Brennan FM, Bijl H, Ghrayeb J, Woody JN. Elliot MJ, et al. Among authors: maini rn. Arthritis Rheum. 2008 Feb;58(2 Suppl):S92-S101. doi: 10.1002/art.23362. Arthritis Rheum. 2008. PMID: 18240199 Free article.

8

Anti-TNF therapy, from rationale to standard of care: what lessons has it taught us?

Feldmann M, Maini RN. Feldmann M, et al. Among authors: maini rn. J Immunol. 2010 Jul 15;185(2):791-4. doi: 10.4049/jimmunol.1090051. J Immunol. 2010. PMID: 20601610 Free article.

9

Detection of transforming growth factor-beta in rheumatoid arthritis synovial tissue: lack of effect on spontaneous cytokine production in joint cell cultures.

Brennan FM, Chantry D, Turner M, Foxwell B, Maini R, Feldmann M. Brennan FM, et al. Clin Exp Immunol. 1990 Aug;81(2):278-85. doi: 10.1111/j.1365-2249.1990.tb03331.x. Clin Exp Immunol. 1990. PMID: 2201470 Free PMC article.

10

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis.

Brennan FM, Chantry D, Jackson A, Maini R, Feldmann M. Brennan FM, et al. Lancet. 1989 Jul 29;2(8657):244-7. doi: 10.1016/s0140-6736(89)90430-3. Lancet. 1989. PMID: 2569055

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

377 results

Search Page

Filters